Treatment of Refractory Anti-HMG-CoA Reductase Myopathy: A Role for Rituximab? [electronic resource]
- The Journal of rheumatology 06 2019
- 550-551 p. digital
Publication Type: Editorial; Research Support, N.I.H., Intramural; Comment
1499-2752
10.3899/jrheum.181392 doi
Humans Hydroxymethylglutaryl CoA Reductases Muscular Diseases Rituximab